Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/10495/34757
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorEscobar Chaves, Elkin Leandro-
dc.contributor.authorAcín Martínez, Sergio-
dc.contributor.authorFernández Culma, Maritza-
dc.contributor.authorMuñoz, Diana Lorena-
dc.contributor.authorEcheverri, Alexandra-
dc.contributor.authorEcheverri López, Luis Fernando-
dc.contributor.authorOrozco Holguín, Jahir-
dc.contributor.authorBalcázar Morales, Norman-
dc.contributor.conferencename(22 : Tetrahedron Symposium. Catalysis for Sustainable World : 28 de junio al 1 de julio de 2022 : Lisboa, Portugal)spa
dc.date.accessioned2023-04-25T16:52:08Z-
dc.date.available2023-04-25T16:52:08Z-
dc.date.issued2022-06-28-
dc.identifier.urihttps://hdl.handle.net/10495/34757-
dc.description.abstractABSTRACT: Triterpene-enriched fractions (OBE100) from Eucalyptus tereticornis demonstrated efficiency when administered intraperitoneally to diet-induced obesity (DIO) mouse model to treat obesity-related type 2 diabetes mellitus (T2DM)1; however, its oral administration has not yet led to satisfactory results. We aimed to develop an oral nano formulation that enhanced the promising effect of the OBE 100 fraction, guaranteeing higher stability and bioavailability of the pharmacologically active components present in the natural extract through the oral route.spa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.type.hasversioninfo:eu-repo/semantics/publishedVersionspa
dc.rightsinfo:eu-repo/semantics/openAccessspa
dc.rightsAtribución-NoComercial-CompartirIgual 2.5 Colombia*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/2.5/co/*
dc.titleNanoformulation prototype based on a natural extract for the potential treatment of type 2 diabetes mellitusspa
dc.typeinfo:eu-repo/semantics/conferenceObjectspa
dc.publisher.groupGenética Molecular (GENMOL)spa
dc.publisher.groupGrupo Tándem Max Planck en Nanobioingenieríaspa
dc.publisher.groupQuímica Orgánica de Productos Naturalesspa
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2spa
oaire.citationtitle22nd Tetrahedron Symposium. Catalysis for Sustainable Worldspa
oaire.citationconferenceplaceLisboa, Portugalspa
oaire.citationconferencedate2022-06-28/2022-07-01spa
thesis.degree.disciplinesin facultad - programaspa
dc.rights.creativecommonshttps://creativecommons.org/licenses/by-nc-sa/4.0/spa
dc.type.coarhttp://purl.org/coar/resource_type/c_5794spa
dc.type.redcolhttps://purl.org/redcol/resource_type/ECspa
dc.type.localDocumento de conferenciaspa
dc.subject.decsDiabetes Mellitus Tipo 2-
dc.subject.decsEucalyptus tereticornis-
dc.subject.decsObesidad-
dc.subject.decsObesity-
dc.subject.decsExtractos Vegetales-
dc.subject.decsPlant Extracts-
dc.description.researchgroupidCOL0006723spa
dc.description.researchgroupidCOL0015339spa
dc.description.researchgroupidCOL0202529spa
Aparece en las colecciones: Documentos de conferencias en Ciencias Exactas y Naturales

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
EscobarElkin_2022_Nanoformulation.pdfPóster1.54 MBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons